Shanghai Medicilon Inc (688202) — Cash Flow-to-Debt Ratio
Shanghai Medicilon Inc (688202) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2023, meaning its operating cash flow of CN¥-17.10 Million could theoretically repay 0% of its total liabilities (CN¥860.98 Million) in one year. See Shanghai Medicilon Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Medicilon Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Shanghai Medicilon Inc across 10 annual periods. Also explore Shanghai Medicilon Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Medicilon Inc (2016–2025)
Year-by-year debt coverage analysis for Shanghai Medicilon Inc. For market capitalisation and broader financial context, see Shanghai Medicilon Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥105.17 Million | CN¥687.85 Million | ▲ +559.2% |
| 2024 | -0.03x | CN¥-22.75 Million | CN¥683.10 Million | ▼ -175.5% |
| 2023 | 0.04x | CN¥33.32 Million | CN¥755.07 Million | ▲ +250.4% |
| 2022 | -0.03x | CN¥-21.33 Million | CN¥726.80 Million | ▼ -103.0% |
| 2021 | 0.97x | CN¥452.94 Million | CN¥466.06 Million | ▲ +7.0% |
| 2020 | 0.91x | CN¥207.77 Million | CN¥228.67 Million | ▲ +99.1% |
| 2019 | 0.46x | CN¥58.30 Million | CN¥127.73 Million | ▼ -19.7% |
| 2018 | 0.57x | CN¥71.11 Million | CN¥125.06 Million | ▼ -22.1% |
| 2017 | 0.73x | CN¥74.70 Million | CN¥102.29 Million | ▲ +111.4% |
| 2016 | 0.35x | CN¥34.13 Million | CN¥98.81 Million | — |